Skip to content
rticc logo
Bruce and Ruth Rappaport Cancer Research Center
  • About
  • Research
  • Members
  • News
  • Join
  • Contact

SUPPORT US
technion logo
D. Dan and Betty Kahn Human Health Building
SUPPORT US
technion logo
D. Dan and Betty Kahn Human Health Building
×
  • About Us
    • Mission and Vision
      • Our History
      • From the Director
    • Leadership & Management
    • Support Us
      • RTICC Supporters
      • Make Your Impact
    • Rappaport-Technion Research Program
    • D. Dan & Betty Kahn Human Health Building
  • Research
    • Cancer Biology
      • The Cancer Cell
      • Cancer Stem Cell
      • Epigenetics & Genomics
      • Metabolism
      • ECM
      • Tumor Microenvironment
      • Cancer Immunology
      • Systems Biology
    • Exact Sciences & Engineering
      • Cancer Chemistry
      • Cancer Biophysics
      • Drug Design
      • Drug Delivery
      • Nanotechnology
      • Imaging
      • Devices
    • Computation & AI
      • Computational Cancer Biology
      • Big Data Analysis
      • Machine Learning
      • AI
    • Translational / Clinical Research
      • Biomarkers
      • Cancer Prevention & Diagnosis
      • Cardio-Oncology
      • Clinical Oncology & Surgical Oncology
      • Drug Discovery
      • Early Clinical Trials
      • Personalized Medicine
      • Targeted Therapy
    • Core Facilities
      • Biomedical Core Facility
      • ATGC Genomics Center
      • Pre-Clinical Research Authority
      • Perlmutter Metabolomics Center
      • Smoler Protein Research Center
      • LS&E
      • The Russell Berrie NNSCC
    • Funding Opportunities
      • RTICC Fellows
    • Research Initiatives
      • “Sarcoma 0-40”
    • Innovation& Inventions
    • RTICC Resources
  • Members
    • RTICC Members
      • Researchers by Topics
      • A-Z Researchers
      • Faculties & Hospitals
    • Partners & Collaborations
    • External Affiliated Researchers
  • News & Events
    • News
    • Seminars & Events
    • Newsletters
  • Join
    • Careers for Faculty Members
    • Scientific Staff Vacancies
    • Post-Doc & Graduate Students Info
  • Contact Us
  • Support Us

About

  • Mission and Vision
    • Our History
    • From the Director
  • Leadership & Management
  • Support Us
    • RTICC Supporters
    • Make Your Impact
  • Rappaport-Technion Research Program
  • D. Dan & Betty Kahn Human Health Building
  • Mission and Vision
    • Our History
    • From the Director
  • Leadership & Management
  • Support Us
    • RTICC Supporters
    • Make Your Impact
  • Rappaport-Technion Research Program
  • D. Dan & Betty Kahn Human Health Building

Research

  • Cancer Biology
    • Cancer Immunology
    • ECM
    • Metabolism
    • Systems Biology
    • Tumor Microenvironment
    • The Cancer Cell
    • Cancer Stem Cell
    • Epigenetics & Genomics
  • Exact Sciences & Engineering
    • Cancer Biophysics
    • Cancer Chemistry
    • Devices
    • Drug Delivery
    • Drug Design
    • Imaging
    • Nanotechnology
  • Computation & AI
    • AI
    • Big Data Analysis
    • Computational Cancer Biology
    • Machine Learning
  • Translational / Clinical Research
    • Biomarkers
    • Cancer Prevention & Diagnosis
    • Cardio-Oncology
    • Clinical Oncology & Surgical Oncology
    • Drug Discovery
    • Early Clinical Trials
    • Personalized Medicine
    • Targeted Therapy
  • Core Facilities
    • Biomedical Core Facility
    • ATGC Genomics Center
    • Pre-Clinical Research Authority
    • Perlmutter Metabolomics Center
    • Smoler Protein Research Center
    • LS&E
    • The Russell Berrie NNSCC
  • Funding Opportunities
    • RTICC Fellows
  • Research Initiatives
    • “Sarcoma 0-40”
  • Innovation& Inventions
  • RTICC Cell Lines Database
  • Cancer Biology
    • Cancer Immunology
    • ECM
    • Metabolism
    • Systems Biology
    • Tumor Microenvironment
    • The Cancer Cell
    • Cancer Stem Cell
    • Epigenetics & Genomics
  • Exact Sciences & Engineering
    • Cancer Biophysics
    • Cancer Chemistry
    • Devices
    • Drug Delivery
    • Drug Design
    • Imaging
    • Nanotechnology
  • Computation & AI
    • AI
    • Big Data Analysis
    • Computational Cancer Biology
    • Machine Learning
  • Translational / Clinical Research
    • Biomarkers
    • Cancer Prevention & Diagnosis
    • Cardio-Oncology
    • Clinical Oncology & Surgical Oncology
    • Drug Discovery
    • Early Clinical Trials
    • Personalized Medicine
    • Targeted Therapy
  • Core Facilities
    • Biomedical Core Facility
    • ATGC Genomics Center
    • Pre-Clinical Research Authority
    • Perlmutter Metabolomics Center
    • Smoler Protein Research Center
    • LS&E
    • The Russell Berrie NNSCC
  • Funding Opportunities
    • RTICC Fellows
  • Research Initiatives
    • “Sarcoma 0-40”
  • Innovation& Inventions
  • RTICC Cell Lines Database

Members

  • RTICC Members
    • Faculty Researchers by Topics
    • A-Z Researchers
    • Faculties & Hospitals
  • Partners & Collaborations
  • External Affiliated Researchers
  • RTICC Members
    • Faculty Researchers by Topics
    • A-Z Researchers
    • Faculties & Hospitals
  • Partners & Collaborations
  • External Affiliated Researchers

News

  • News
    • Newsletters
  • Seminars and Events
  • News
    • Newsletters
  • Seminars and Events

Join

  • Careers for Faculty Members
  • Scientific Staff Vacancies
  • Post-Doc & Graduate Students Info
  • Careers for Faculty Members
  • Scientific Staff Vacancies
  • Post-Doc & Graduate Students Info

Posts Tagged ‘Ubiquitin Biology’

Diefenbacher Markus

Markus Diefenbacher, Helmholtz Munich

Helmholtz Munich
markus.diefenbacher@helmholtz-munich.de

Read More

All Tags:

Adverse Effects (1) Aging (2) AI (18) anti-cancer small molecules (1) Apoptosis (1) ARTS (1) Big Data Analysis (21) Bioethics (1) Biomarkers (27) Breast Cancer (3) Cancer Biophysics (9) Cancer Cell Biology (1) Cancer Chemistry (8) Cancer Immunology (27) cancer metabolism (1) Cancer Models (1) Cancer Prevention and Diagnosis (30) Cancer Stem Cell (3) Cancer Therapeutics (1) Cannabis and Endocannabinoid system (2) Cardiac Remodeling (1) Cardio-oncology (3) CAR T cells (2) Cell death (2) Chronic Hypertension (1) Clinical Oncology & Surgical Oncology (17) Colorectal Cancer (1) Computational Cancer Biology (12) Congenital and acquired bone marrow failure (1) CRISPR/Cas9 (1) Decision-making and Precision Medicine (1) Degradation (1) Devices (10) DNA methylation (1) Drug Delivery (18) Drug Design (14) Drug Discovery (20) Early Clinical Trials (12) ECM (13) epige (1) Epigenetics & Genomics (26) Evaluation (1) Ewing Sarcoma (1) Fibrosis (2) Genetics (2) Hereditary cancer syndromes (1) Human Disease Models (1) Imaging (28) Immuno-oncology (3) Immunotherapy (7) Kaposi (1) Liquid Biopsy (1) Lung Cancer (2) Machine Learning (21) Macrophage Polarization (1) Metabolism (7) metabolomics (1) Metastasis (4) Microbiome (2) Microphysiological Systems (1) Modeling of Human Disease in Zebrafish and Yeast (1) Monitoring (1) MRI (5) Nanotechnology (14) Nsclc (1) Onconeural Autoimmunity (1) Organ-on-Chip (1) Pediatric Oncology (3) Pediatric Solid Tumors (1) Personalized Medicine (34) Pioneer Factors (1) Platelet Biology (1) PROTAC (1) Proteasome (2) Protein Degradation (2) Psychosocial (1) Radiotherapy (1) Regulatory T Cells (2) Reproducible Scientific Discovery (1) Researcher (94) Reverse Cardio-Oncology (1) Ribosomopathies (1) Sarcoma (1) Socioeconomic Status (1) Stem Cell (3) Supportive Care (1) System Biology (19) Targeted Therapy (32) The Cancer Cell (33) Therapy Resistance (1) Tissue-Resident Macrophages (1) Tissue Engineering (1) Toxicity of cancer therapy (1) Tumor-Educated Platelets (TEPs) (1) Tumor Microenvironment (30) Ubiquitin (3) Ubiquitin-Proteasome System (1) Ubiquitin Ligases (3) VTE (1) XIAP (1)

RTICC - Bruce and Ruth Rappaport Cancer Research Center
technion logo
D. Dan and Betty Kahn Human Health Building white logo

© 2026 RTiCC
Bruce and Ruth Rappaport Cancer Research Center
Accessibility Statement | Privacy Policy

Scroll To Top